$ORCLBearishMed

ASX set to jump, Wall Street rebounds as Trump calls off Iran attacks

US stocks rose after President Donald Trump said talks with Iran were approved at the highest Iranian leadership level and that a signing’s time and place will be announced. S&P 500 +1.3%, Dow +1.6%, Nasdaq +1.8%. Oil fell: WTI -2.8% to $87.56, Brent -3.5% to $89.84. ASX futures pointed to a 1.2% open gain.

7/10
4/10
Med
Bearish
immediate pre-market / same-day macro impulse after Trump’s Iran announcement
Risk-on: equities up, oil down, Treasury yields easing; semis/AI names bid.

Capital-raise guidance for AI funding is a near-term overhang for ORCL equity and could pressure valuation multiples.

Oracle shares fell 11% after it reported stronger profit but said it expects to raise $40B via borrowing and stock sales for AI spending.

Bearish near-term bias; follow-through risk if investors treat the $40B raise as dilution/financing risk.

Background

Trump’s statement that discussions with Iran were approved at the highest Iranian leadership level is framed as a call-off of imminent attacks, shifting markets from geopolitical risk to oil/rates relief.

Why it matters

Falling oil reduces inflation pressure and eases Treasury yields, supporting equity risk appetite; however, company-specific financing plans (notably ORCL) can still create idiosyncratic downside.

Market relevance

This is a macro-to-equities transmission story: Iran de-escalation → oil down → yields down → risk-on in AI/semis, with ORCL providing a notable counterweight via financing guidance.

Market effects

Oil-price drop and easing inflation pressure can support rate-sensitive growth/AI/semis; semicap rallies appear macro-driven.

ASX futures point to a ~1.2% open gain, implying global risk-on spillover from US de-escalation and lower oil.

De-escalation raises odds of renewed Strait of Hormuz flows, pressuring crude and influencing global inflation/rate expectations.

Alternative perspectives

The rally may be fragile: AI/semis are described as prone to rapid reversals, and ORCL’s financing/dilution overhang shows fundamentals can still dominate.

If oil stabilizes higher again or inflation data re-accelerates, rate-cut expectations could unwind quickly, reversing the macro tailwind for growth/AI equities.

Key entities

  • Donald Trump

    US President whose Iran de-escalation statement triggered immediate market repricing.

  • Oracle

    Reported stronger profit but guided to $40B cash raising via borrowing and stock sales for AI investments.

  • Lam Research

    Semiconductor equipment name that rallied with the broader chip/AI rebound.

  • KLA

    Semicap name that jumped alongside the chipmaker rally.

  • Marvell Technology

    AI/semis stock that rose as the market rebounded after the Iran announcement.

Related articles

$AMZNMed

Top Wall Street analysts are confident about these 3 stocks for the long haul

TipRanks highlights three long-term stock picks amid geopolitical and AI-demand concerns. TD Cowen reiterated a buy on Amazon (AMZN), cutting its price target to $340 and forecasting Q2 revenue of $200.1B, with AWS revenue up 35.5% YoY. RBC reiterated buy on Marvell (MRVL) with a $360 target. Wells Fargo reiterated buy on AMD, raising its price target to $615 and lifting server CPU and GPU estimates for 2026-2028.

$LRCXMed

Hidden AI chip supplier poised to blow past Wall Street targets

Lam Research (LRCX) is set to report fiscal Q4 earnings on July 29, 2026. Morgan Stanley expects revenue of $7.4B versus $7.0B consensus, and projects the WFE market outlook rising from $140B to $145B. The firm rates LRCX “overweight” with a $404 target. Analysts cite AI-driven demand and cleanroom capacity constraints.

$MRVLMedAI 8/10

5 Under the Radar AI Chip Stocks Powering the Data Center Boom

The article highlights AI data-center chip and connectivity stocks, citing YTD gains for MRVL (+187%) and ALAB (+151%). It reports Marvell Q1 FY2027 revenue $2.418B and Arm Q4 FY2026 revenue $1.49B with data-center royalties up. It also cites Cerebras’ $20B OpenAI inference deal and $1B loan, plus MACOM Q2 FY2026 revenue $288.95M.

$AMATMedAI 8/10

These 5 Chip Stocks Are Riding the AI Fab Spending Wave

The article highlights AI-driven semiconductor capex and profiles five equipment/testing stocks. Applied Materials (AMAT) raised its 2026 semiconductor equipment growth forecast to over 30%. Onto Innovation (ONTO) reported Q1 revenue of $291.95M and a $240M+ HBM purchase agreement through 2027. It also cites record results for Lam Research (LRCX), KLA (KLAC), and Teradyne (TER).

$ORCLMed

Environmental Groups Sue DNR Over Port Washington Data Center Review

Two environmental groups sued Wisconsin’s DNR, alleging it skipped a full environmental impact statement for Vantage’s Port Washington data center. The groups cite communications showing Vantage sought to avoid the EIS. The project is described as a $15 billion, 672-acre build with 1.3 GW power in phase one. Separate disputes involve a Wisconsin Public Service Commission energy tariff affecting Oracle’s collateral appeal.

$MUMed

Micron Jumps as Chip Sentiment Improves

Micron Technology (MU) rose about 8% after it increased planned U.S. manufacturing and technology investment to over $250 billion through 2035, from $200 billion. Chip and optical stocks also gained as Broadcom (AVGO) moved up on an Apple partnership expected to exceed $30 billion. Sandisk, AMD, Marvell, and Lumentum rose on analyst and sentiment updates.